VF
SNOA icon

Virtu Financial’s Sonoma Pharmaceuticals SNOA Stock Holding History

Virtu Financial’s Portfolio SNOA Stock Details SNOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-737
Closed -$16K – 1852
2023
Q2 		$16K Sell
737
-66
-8% -$1.36K ﹤0.01% 1297
2023
Q1 		$16K Buy
+803
New +$20.7K ﹤0.01% 1287
2021
Q4 		– Sell
-1,063
Closed -$119K – 2140
2021
Q3 		$119K Buy
+1,063
New +$131K 0.01% 1088
2019
Q2 		– Sell
-400
Closed -$67K – 1830
2019
Q1 		$67K Buy
+400
New +$60.5K ﹤0.01% 1182
2018
Q3 		– Sell
-152
Closed -$68K – 2128
2018
Q2 		$68K Buy
+152
New +$99.1K ﹤0.01% 1718

Other funds holding SNOA

TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AF
Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Virtu Financial's SNOA Position: Q3 2023 in Review

Virtu Financial sold out of Sonoma Pharmaceuticals (SNOA) in Q3 2023, closing a stake of 737 shares — an estimated $16K sold.

Virtu Financial first reported a position in SNOA in Q2 2018 and held it in 5 quarters. The position peaked at $119K in Q3 2021. 12 funds tracked by Wall St. Rank hold SNOA as of Q3 2023.

  • Virtu Financial reported no remaining Sonoma Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Virtu Financial sold 737 Sonoma Pharmaceuticals shares in Q3 2023, an estimated $16K.
  • Virtu Financial first reported a position in Sonoma Pharmaceuticals in Q2 2018 and held it in 5 quarters.
  • Virtu Financial's Sonoma Pharmaceuticals position peaked at $119K in Q3 2021.
  • 12 funds tracked by Wall St. Rank held Sonoma Pharmaceuticals as of Q3 2023.

Based on Virtu Financial's 13F filing for Q3 2023, filed 15 Nov 2023.